CVS Returns Zepbound to Drug Plans After Lilly Slashes Price - Bloomberg.com
More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans.... Read More
Source: Bloomberg
Published: 2026-05-28T13:43:34Z
Author: Ike Swetlitz, Madison Muller